Tennr Raises $101M to Revolutionize Patient Referrals with AI

Tennr's Breakthrough in Healthcare Technology

Tennr, a New York-based health tech startup, has successfully raised $101 million in a Series C funding round, propelling its valuation to $605 million 1

1

. This significant investment, led by venture capital firm IVP with participation from existing investors including Andreessen Horowitz and Lightspeed, positions Tennr as one of the fastest-growing health tech startups in the AI-dominated healthcare sector 1

1

2

2

.

Addressing the Patient Referral Challenge

Founded in 2021 by Trey Holterman, Tyler Johnson, and another co-founder, Tennr aims to solve a pervasive issue in the U.S. healthcare system: the inefficient patient referral process 1

1

. The company's mission is to eliminate delays, denials, and dropped services that often occur when patients are referred from primary care to specialists. With one-third of Americans referred for specialty care annually and more than half never making it to the next step, Tennr's solution addresses a critical gap in healthcare delivery 1

1

.

AI-Powered Document Intelligence

At the core of Tennr's innovation is its proprietary artificial intelligence model, specifically designed for patient referrals 1

1

2

2

. The company has trained its large language models on over 100 million medical documents, 2.3 billion distinct data fields, and 8,000 sets of criteria 2

2

. This specialized approach allows Tennr to:

1. Decipher complex medical paperwork
2. Automate the referral process
3. Determine key details such as eligibility, benefits, and payer rules

Tennr's AI can even interpret notoriously difficult doctor's handwriting, a feat that sets it apart from general-purpose AI models 1

1

.

Beyond AI: Focusing on Solutions

While AI is central to Tennr's technology, CEO Trey Holterman emphasizes the company's focus on solving real-world problems rather than simply promoting AI capabilities 1

1

. "I want to talk about problems and I want to talk about solutions," Holterman stated, highlighting Tennr's commitment to practical applications of its technology 1

1

.

Expanding Services and Future Growth

Tennr is not limiting itself to referral processing. The company is expanding its product offerings to include:

1. A network feature for primary care physicians and patients to track referrals and payments 1

   1

2. Tools for verifying insurance information 1

   1

3. Transcript Translation Technology (T3) for parsing medical call transcripts into actionable data 2

   2

These expansions demonstrate Tennr's potential for growth in various subverticals within medical specialties.

Financial Performance and Market Position

While specific financial figures were not disclosed, Holterman revealed that Tennr's revenue is in the eight-figure range, having tripled since its Series B round in October 1

1

. This rapid growth, coupled with its strategic position in the healthcare market, has attracted significant investor interest.

As the healthcare industry increasingly looks to AI for solutions, Tennr's specialized approach and focus on tangible outcomes position it well for continued success. By ensuring patients receive necessary services and understand associated costs, Tennr is not just automating work but improving healthcare delivery and patient outcomes 1

1

2

2

.